These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38334078)

  • 1. pH-sensitive docetaxel-loaded chitosan/thiolated hyaluronic acid polymeric nanoparticles for colorectal cancer.
    Noreen S; Pervaiz F; Ijaz M; Hanif MF; Hamza JR; Mahmood H; Shoukat H; Maqbool I; Ashraf MA
    Nanomedicine (Lond); 2024 Apr; 19(9):755-777. PubMed ID: 38334078
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
    Samprasit W; Opanasopit P; Chamsai B
    J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1221-1233. PubMed ID: 34919783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
    Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
    Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
    Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
    Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
    Samprasit W; Opanasopit P; Chamsai B
    Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
    Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
    Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells.
    Nokhodi F; Nekoei M; Goodarzi MT
    J Mater Sci Mater Med; 2022 Feb; 33(2):24. PubMed ID: 35157166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab.
    Pang J; Xing H; Sun Y; Feng S; Wang S
    Biomed Pharmacother; 2020 May; 125():109861. PubMed ID: 32070872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
    Wang X; Cheng R; Zhong Z
    Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
    Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
    Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
    Dong Z; Wang Y; Guo J; Tian C; Pan W; Wang H; Yan J
    Drug Des Devel Ther; 2022; 16():2683-2693. PubMed ID: 35983428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.
    Radwan SE; El-Kamel A; Zaki EI; Burgalassi S; Zucchetti E; El-Moslemany RM
    Int J Nanomedicine; 2021; 16():4481-4494. PubMed ID: 34239300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
    Umerska A; Corrigan OI; Tajber L
    Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
    Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
    Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
    Verheul RJ; Sl├╝tter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE
    J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.